Aibotics Inc. AIBT · Stock Open Aibotics Inc. in new tab

0.002200 USD

Add to portfolio

P/E

0.21

EPS

0.01

P/B

-0.35

Beta

0.73

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF valuation

Model fair value for Aibotics Inc. (AIBT)

Result

Sign in to run the valuation for AIBT.

Model fair value

–

Price

–

Model vs price

–

WACC – Terminal value PV – Σ PV of cash flows –

Fair value per share by discount rate (rows) and terminal growth (columns)
WACC \ g

Assumptions

Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Aibotics Inc. Analysis (AIBT)

USA Official Website Stock

Is Aibotics Inc. a good investment? Aibotics Inc. (AIBT) is currently trading at 0.002200 USD.

In terms of valuation, the stock trades at a P/E ratio of 0.21. This relatively low multiple may signal that Aibotics Inc. is undervalued compared to historical market norms.

Investor FAQ

Does Aibotics Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Aibotics Inc.?

Aibotics Inc. is classified as a Stock.

Company Profile

Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic-enhanced holistic methodologies for the treatment of palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025. Aibotics Inc. is based in Miami, Florida.

Trades

Dividend History paid per year (USD)

No dividend history available.

Stock Splits

Split Date	Split Ratio to 1
May 1, 2014	2:1

Fundamentals

2026 © AllInvestView

Twitter YouTube Reddit Feature Requests Changelog Support Pricing Help

Support email: [email protected]

Terms of Service | Privacy Policy

Free Trackers · Dividend Apps · Tax Reporting · UK · Australia · Germany · Guides · Ticker Logos

Stock Directory · Financial Glossary · Portfolio Templates · Top Dividend Stocks · Investing in US · Investing in UK · Import Guides · Stock Comparison · Earnings Recaps

Data disclaimer: AIV (AllInvestView) assumes no liability for the information presented. Users are encouraged to exercise caution and carefully consider the accuracy, completeness, and relevance of the information provided.

It's important to remember that our website should complement your independent market research rather than replace it. The past performance of assets should not be regarded as a guarantee of future results. AllInvestView is not a registered investment advisor or broker/dealer, and the information presented here is for educational and informational purposes only. We value your trust and are committed to providing you with valuable market insights while emphasizing the importance of responsible decision-making in your investment journey.